FWP Forward Pharma A/S

5.67
-0.14  -2%
Previous Close 5.81
Open 5.67
Price To Book 3.38
Market Cap 269,534,404
Shares 47,536,932
Volume 11,058
Short Ratio
Av. Daily Volume 581
Stock charts supplied by TradingView

NewsSee all news

  1. Forward Pharma A/S Announces Change in Ratio of American Depositary Shares to Ordinary Shares

    COPENHAGEN, Denmark, Nov. 26, 2019 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) ("Forward" or the "Company") today announced that its Board of Directors has approved a change in the number of its ordinary shares

  2. Forward Pharma to Participate in the Fall Investor Summit in New York

    COPENHAGEN, DENMARK / ACCESSWIRE / Sep. 5, 2019 / Forward Pharma A/S (NASDAQ:FWP) (the "Company") today announced that Chief Executive Officer, Dr. Claus Bo Svendsen, will participate in the Fall Investor Summit investor

  3. Forward Pharma to Participate in the Fall Investor Summit in New York

    COPENHAGEN, Denmark, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the "Company") today announced that Chief Executive Officer, Dr. Claus Bo Svendsen, will participate in the Fall Investor Summit

Drug Information

Drug catalyst information is displayed when you hover over / tap on the stage bar graph.

Latest News

  1. Forward Pharma A/S Announces Change in Ratio of American Depositary Shares to Ordinary Shares

    COPENHAGEN, Denmark, Nov. 26, 2019 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) ("Forward" or the "Company") today announced that its Board of Directors has approved a change in the number of its ordinary shares

  2. Forward Pharma to Participate in the Fall Investor Summit in New York

    COPENHAGEN, DENMARK / ACCESSWIRE / Sep. 5, 2019 / Forward Pharma A/S (NASDAQ:FWP) (the "Company") today announced that Chief Executive Officer, Dr. Claus Bo Svendsen, will participate in the Fall Investor Summit investor

  3. Forward Pharma to Participate in the Fall Investor Summit in New York

    COPENHAGEN, Denmark, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the "Company") today announced that Chief Executive Officer, Dr. Claus Bo Svendsen, will participate in the Fall Investor Summit